| 000 | 01780 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513211838.0 | ||
| 264 | 0 | _c20000629 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Der Kolk, D M | |
| 245 | 0 | 0 |
_aDeletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity. _h[electronic resource] |
| 260 |
_bBlood _cJun 2000 |
||
| 300 |
_a3514-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBase Pair Mismatch |
| 650 | 0 | 4 |
_aBone Marrow Cells _xcytology |
| 650 | 0 | 4 | _aCarcinoma, Small Cell |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChromosome Inversion |
| 650 | 0 | 4 | _aChromosome Mapping |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 16 |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aDoxorubicin _xtoxicity |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
| 650 | 0 | 4 | _aLung Neoplasms |
| 650 | 0 | 4 | _aMultidrug Resistance-Associated Proteins |
| 650 | 0 | 4 | _aMutS Homolog 3 Protein |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aVellenga, E | |
| 700 | 1 | _avan Der Veen, A Y | |
| 700 | 1 | _aNoordhoek, L | |
| 700 | 1 | _aTimmer-Bosscha, H | |
| 700 | 1 | _aOssenkoppele, G J | |
| 700 | 1 | _aRaymakers, R A | |
| 700 | 1 | _aMüller, M | |
| 700 | 1 | _avan Den Berg, E | |
| 700 | 1 | _ade Vries, E G | |
| 773 | 0 |
_tBlood _gvol. 95 _gno. 11 _gp. 3514-9 |
|
| 999 |
_c10779597 _d10779597 |
||